Funder
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Dr. Ralph and Marian Falk Medical Research Trust
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
The Harrington Discovery Institute accelerates promising discoveries into medicines for unmet needs
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Nguyen, K. T., Holloway, M. P. & Altura, R. A. The CRM1 nuclear export protein in normal development and disease. Int. J. Biochem. Mol. Biol. 3, 137–151 (2012).
2. Camus, V., Miloudi, H., Taly, A., Sola, B. & Jardin, F. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy. J. Hematol. Oncol. 10, 47 (2017).
3. Kudo, N. et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl Acad. Sci. USA 96, 9112–9117 (1999).
4. Ferreira, B. I., Cautain, B., Grenho, I. & Link, W. Small molecule inhibitors of CRM1. Front. Pharm. 11, 625 (2020).
5. Chari, A. et al. Oral selinexor-dexamethasone for triple-class refractory multiple myeloma. N. Engl. J. Med. 381, 727–738 (2019).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献